?A quién beneficia el comercio paralelo de medicamentos en la Unión Europea?
Year of publication: |
2009
|
---|---|
Authors: | Costa-Font, Joan ; Kanavos, Panos |
Published in: |
El trimestre económico. - Mexico : Fondo, ISSN 0041-3011, ZDB-ID 2084776. - Vol. 76.2009, 302, p. 331-348
|
Saved in:
Saved in favorites
Similar items by person
-
Competition in off-patent drug markets : issues, regulation and evidence
Kanavos, Panos, (2008)
-
Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia
Costa-Font, Joan, (2007)
-
Kanavos, Panos, (2007)
- More ...